These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26033397)

  • 1. Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities.
    Eckman MH; Alonso-Coello P; Guyatt GH; Ebrahim S; Tikkinen KA; Lopes LC; Neumann I; McDonald SD; Zhang Y; Zhou Q; Akl EA; Jacobsen AF; Santamaría A; Annichino-Bizzacchi JM; Bitar W; Sandset PM; Bates SM
    Thromb Res; 2015 Aug; 136(2):341-7. PubMed ID: 26033397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview.
    Bates SM; Alonso-Coello P; Tikkinen KA; Ebrahim S; Lopes LC; McDonald SD; Zhou Q; Akl EA; Neumann I; Jacobsen AF; Zhang Y; Santamaría A; Annichino-Bizzacchi JM; Sandset PM; Bitar W; Eckman MH; Guyatt GH
    Thromb Res; 2016 Apr; 140():22-9. PubMed ID: 27500301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol.
    Alonso-Coello P; Ebrahim S; Guyatt GH; Tikkinen KA; Eckman MH; Neumann I; McDonald SD; Akl EA; Bates SM
    BMC Pregnancy Childbirth; 2012 May; 12():40. PubMed ID: 22646475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferences of pregnant women for postpartum thromboprophylaxis: the bicentric PREFER-PostPartum study.
    Blondon M; Lansiaux M; Bryan S; Dongala A; Pavoncello R; Chatellier G; Claver M; Azria E; Martinez de Tejada B; Hugon-Rodin J
    J Thromb Haemost; 2024 Oct; 22(10):2834-2843. PubMed ID: 38972385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review.
    León-García M; Humphries B; Maraboto A; Rabassa M; Boehmer KR; Perestelo-Perez L; Xie F; Pelayo I; Eckman M; Bates S; Selva A; Alonso-Coello P
    BMC Pregnancy Childbirth; 2022 Oct; 22(1):747. PubMed ID: 36199014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of thromboprophylaxis with enoxaparin for prevention of pregnancy-associated venous thromboembolism.
    Cox S; Eslick R; McLintock C
    J Thromb Haemost; 2019 Jul; 17(7):1160-1170. PubMed ID: 31013386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thromboprophylaxis with low-molecular-weight heparin insufficient in high-risk pregnancy].
    Roeters van Lennep JE; Meijer E; Klumper FJ; Middeldorp JM; Bloemenkamp KW; Middeldorp S
    Ned Tijdschr Geneeskd; 2011; 155():A3433. PubMed ID: 21527059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thromboprophylaxis in pregnant women should be individually tailored].
    Spaanderman MA
    Ned Tijdschr Geneeskd; 2011; 155(18):A3568. PubMed ID: 21557830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Values and preferences towards the use of prophylactic low-molecular-weight heparin during pregnancy: a convergent mixed-methods secondary analysis of data from the decision analysis in shared decision making for thromboprophylaxis during pregnancy (DASH-TOP) study.
    León-García M; Humphries B; Xie F; Gravholt DL; Golembiewski E; Eckman MH; Bates SM; Hargraves I; Pelayo I; López SR; Caño JAM; Alcántara MAS; D'Souza R; Shehata N; Jack SM; Guyatt G; Perestelo-Perez L; Alonso-Coello P
    Thromb J; 2024 Sep; 22(1):81. PubMed ID: 39243049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
    Galambosi PJ; Ulander VM; Kaaja RJ
    Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological Thromboprophylaxis during Pregnancy and the Puerperium: Recommendations from Current Guidelines and their Critical Comparison].
    Rath W; Tsikouras P; von Tempelhoff GF
    Z Geburtshilfe Neonatol; 2016 Jun; 220(3):95-105. PubMed ID: 27315397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between prophylactic low-molecular-weight heparin use in pregnancy and macrosomia: analysis of the Ottawa and Kingston birth cohort.
    Lowry DE; Corsi DJ; White RR; Guo M; Lanes A; Smith G; Rodger M; Wen SW; Walker M; Gaudet L
    J Thromb Haemost; 2019 Feb; 17(2):345-349. PubMed ID: 30552749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thromboprophylaxis during pregnancy and the puerperium: highlights from current guidelines].
    Rath W
    Z Geburtshilfe Neonatol; 2010 Dec; 214(6):217-28. PubMed ID: 21207321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevention of pregnancy-related venous thromboembolism.
    Guimicheva B; Czuprynska J; Arya R
    Br J Haematol; 2015 Jan; 168(2):163-74. PubMed ID: 25312482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism.
    Lindqvist PG; Bremme K; Hellgren M;
    Acta Obstet Gynecol Scand; 2011 Jun; 90(6):648-53. PubMed ID: 21314819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight-adjusted LMWH prophylaxis provides more effective thrombin inhibition in morbidly obese pregnant women.
    Ismail SK; Norris L; O'Shea S; Higgins JR
    Thromb Res; 2014 Aug; 134(2):234-9. PubMed ID: 24984985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery.
    Blondon M; Perrier A; Nendaz M; Righini M; Boehlen F; Boulvain M; De Moerloose P
    Thromb Haemost; 2010 Jan; 103(1):129-37. PubMed ID: 20062923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed methods pilot study protocol.
    Humphries B; León-García M; Bates S; Guyatt G; Eckman M; D'Souza R; Shehata N; Jack S; Alonso-Coello P; Xie F
    BMJ Open; 2021 Mar; 11(3):e046021. PubMed ID: 33753445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19.
    D'Souza R; Malhamé I; Teshler L; Acharya G; Hunt BJ; McLintock C
    Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1110-1120. PubMed ID: 32678949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.